Search Results

Business

UroGen Pharma Appoints David Lin as New Chief Commercial Officer

UroGen Pharma Ltd. today announced that David Lin will join UroGen as its Chief Commercial Officer and member of the Executive Leadership Team.

June 3, 2024

·

11 min read

Press Releases

UroGen Pharma to Present at the Guggenheim Securities Healthcare Innovation Conference

November 5, 2024

·

1 min read

Deals

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 7, 2024

UroGen Pharma Ltd. today announced the grants of inducement restricted stock units (“RSUs”) and an option (“Option”) to 15 new employees in connection with their employment with UroGen.

June 7, 2024

·

2 min read

Pharm Country

UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants

UroGen Pharma Ltd. announced that it has commenced an underwritten public offering, subject to market and other conditions, to issue and sell its ordinary shares and pre-funded warrants.

June 17, 2024

·

4 min read

Press Releases

UroGen Appoints Chris Degnan as Chief Financial Officer

October 9, 2024

·

5 min read

Press Releases

UroGen Pharma to Report Third Quarter Financial Results on Wednesday, November 6, 2024

October 30, 2024

·

1 min read

Pharm Country

UroGen Pharma to Host UGN-102 Virtual Data Event on June 13, 2024

UroGen Pharma Ltd. today shared additional details about the upcoming ENVISION virtual data event on Thursday, June 13, 2024, at 11:00 a.m. Eastern Time.

June 6, 2024

·

4 min read

Pharm Country

UroGen Pharma to Participate at Upcoming May 2024 Investor Conferences

UroGen Pharma Ltd., a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, announced that it will present at the following investor conferences in May.

May 7, 2024

·

1 min read

FDA

UroGen Announces FDA Acceptance of its New Drug Application for UGN-102

October 15, 2024

·

7 min read

Pharm Country

UroGen Pharma to Present at the 45th Annual Goldman Sachs Global Healthcare Conference

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that management will participate in a fireside chat at the 45th Annual Goldman Sachs Global Healthcare Conference to take place June 10-13, 2024.

June 5, 2024

·

1 min read